oxyglobin
opk biotech netherlands bv - hemoglobin glutamer-200 (goveda) - krvnim pripravcima i perfuzijske otopine - psi - oxyglobin pruža prenose kisik u prilog pasa poboljšanje kliničkih znakova anemije u roku od najmanje 24 sata, bez obzira na glavne bolesti.
trinity biotech in vitro dijagnostika
jasika d.o.o., zagreb - reagensi, kontrole i pomoćni materijali za in vitro dijagnostiku zaraznih bolesti
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
tookad
steba biotech s.a - padeliporfin di-kalija - prostatske neoplazme - antineoplastična sredstva - tookad prikazan kao monoterapija za liječenje odraslih bolesnika s prethodno liječenih liječenje, jednostrano, nizak rizik, аденокарцинома prostate s očekivanom trajanju života ≥ 10 godina:klinička faza Т1с ili t2a;na skali Глисона ≤ 6, na temelju visoke rezolucije biopsije strategije;psa ≤ 10 ng/ml;3 pozitivan rak jezgre s najvećom raka jezgre dužine 5 mm u bilo kojem jednoj jezgri ili 1-2 pozitivnom raku jezgre s ≥ 50 % raka implikacija na bilo koji jedan kernel ili gustoća psa ≥ 0. 15 ng/ml/cm3.
maco biotech freezing - eva vreĆice za zamrzavanje stanica, eva vreĆice za zamrzavanje tkiva i posude za Čuvanje
jasika d.o.o., zagreb - vrećice i posude za zamrzavanje i čuvanje stanica i tkiva
maco biotech kontejneri za krv iz pupkovine
jasika d.o.o., zagreb - kontejneri za uzimanje, čuvanje i redukciju volumena krvi iz pupkovine
horse allo 20
centauri biotech sl - аллогенная konja masnih мезенхимальных matičnih stanica - konji - za liječenje артроза kod odraslih ne prehrambene proizvode konja.
humira
abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresivi - molimo pogledajte dokument s informacijama o proizvodu.
humira 40 mg/0.8 ml otopina za injekciju
abbvie d.o.o. - adalimumab - otopina za injekciju - 40 mg/0.8 ml - 0,8 ml otopine za injekciju sadrži: 40 mg adalimumaba